Skip to main content
. 1999 Feb;43(2):400–402. doi: 10.1128/aac.43.2.400

TABLE 1.

Susceptibilities of PAO1 and its β-lactamase- and/or efflux system-deficient mutants to various β-lactams

Group and antimicrobial agent MIC (μg/ml)a
PAO1 KG2239 KG2504 KG2507
Group I
 Carbenicillin 25 0.39 25 0.10
 Piperacillin 1.56 0.20 1.56 0.05
 Cefoperazone 3.13 0.39 1.56 0.10
 Aztreonam 3.13 0.10 1.56 0.05
 Cefsulodin 0.78 0.20 0.78 0.20
Group II
 Amoxicillin 3,200 1,600 6.25 0.10
 Cefmetazole 1,600 1,600 100 0.20
 Flomoxef 6,400 6,400 12.5 0.20
 Panipenem 3.13 3.13 0.20 0.10
 Imipenem 0.78 0.78 0.20 0.20
Group III
 Cefpodoxime 400 400 100 0.20
 Cefuroxime 800 400 400 0.78
 Ceftriaxone 6.25 12.5 3.13 0.20
 Moxalactam 6.25 3.13 6.25 0.39
 Meropenem 0.39 0.20 0.20 0.012
 S-4661 0.20 0.39 0.10 0.025
a

PAO1 produced AmpC and MexAB-OprM, KG2239 produced AmpC but was MexAB-OprM deficient, KG2504 was AmpC deficient but produced MexAB-OprM, and KG2507 was AmpC and MexAB-OprM deficient.